Contents
Current Drug Targets - Inflammation & Allergy, Volume 3 - Number 3
Glycosaminoglycans and the Regulation of Allergic Inflammation
, 3(3): 221 - 225Mark J. Rose and Clive Page
DOI: 10.2174/1568010043343589
Anti-IgE Monoclonal Antibody (Omalizumab) in the Treatment of Atopic Asthma and Allergic Respiratory Diseases
, 3(3): 227 - 229Gennaro D'Amato, Gennaro Liccardi, Paolo Noschese, Antonello Salzillo, Maria D'Amato and Mario Cazzola
DOI: 10.2174/1568010043343615
The Potential of PDE4 Inhibitors in Respiratory Disease
, 3(3): 231 - 236Domenico Spina
DOI: 10.2174/1568010043343822
Potential Role of Antibiotics in the Treatment of Asthma
, 3(3): 237 - 242Francesco Blasi, Roberto Cosentini, Paolo Tarsia and Luigi Allegra
DOI: 10.2174/1568010043343624
Targeting Th2 Cells in Asthmatic Airways
, 3(3): 243 - 255Gaetano Caramori, Kazuhiro Ito and Ian M. Adcock
DOI: 10.2174/1568010043343750
Chemokine Receptor Inhibitors as a Novel Option in Treatment of Asthma
, 3(3): 257 - 261Ian M. Adcock and Gaetano Caramori
DOI: 10.2174/1568010043343660
Cytokine-Directed Therapy in Asthma
, 3(3): 263 - 269Masakazu Ichinose and Peter J. Barnes
DOI: 10.2174/1568010043343688
Anti-Inflammatory Activities of α2-Agonists
, 3(3): 271 - 277Nicola A. Hanania and Robert H. Moore
DOI: 10.2174/1568010043343598
Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis
, 3(3): 279 - 290Diane M. Muller, Michael P. Pender and Judith M. Greer
DOI: 10.2174/1568010043343732
Dendritic Cell-Based Therapies in the Bench and the Bedsides
, 3(3): 305 - 310Sk. Md. Fazle Akbar, Hidehiro Murakami, Norio Horiike and Morikazu Onji
DOI: 10.2174/1568010043343787
Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy
, 3(3): 311 - 315Connie W. Lam and Stephen J. Getting
DOI: 10.2174/1568010043343606
Cytokine and Nitric Oxide Production Following Severe Envenomation
, 3(3): 325 - 332Vera L. Petricevich
DOI: 10.2174/1568010043343642
Webmaster Contact: info@benthamscience.org